tiprankstipranks
Trending News
More News >
Karyopharm Therapeutics INC (KPTI)
:KPTI

Karyopharm Therapeutics (KPTI) Revenue

Compare
1,176 Followers

Karyopharm Therapeutics Revenue

Karyopharm Therapeutics had a revenue of 30.54M in the quarter ending Dec 31, 2024, with -21.25%. This bring the company's revenue in the last twelve months to 145.24M, Increased -2.16%. In the fiscal year ending Dec 31, 2024, Karyopharm Therapeutics had annual revenue of 145.24M with -0.55% growth.
Revenue (ttm)
145.24M
Revenue Growth
-0.55%
P/S Ratio
0.33
Revenue/Employee
$520,563
Employees
279
Market Cap
$48.16M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024145.24M-796.00K-0.55%
Dec 31, 2023146.03M-11.04M-7.03%
Dec 31, 2022157.07M-52.74M-25.14%
Dec 31, 2021209.82M101.73M+94.12%
Dec 31, 2020108.08M67.19M+164.31%
Dec 31, 201940.89M10.56M+34.80%
Dec 31, 201830.34M28.73M+1,790.09%
Dec 31, 20171.60M1.45M+942.21%
Dec 31, 2016154.00K-96.00K-38.40%
Dec 31, 2015250.00K21.00K+9.17%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis